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Opening Statement
Purpose in Pursuing the DNP
At a very young age I knew I wanted to have a career that was challenging and
interesting but more importantly, would make a difference in people’s everyday lives. It
was more about what career would be best to give back rather than what a career could
do for me.
I worked in the emergency department as a registered nurse for 8 years, caring for
patients in an underserved area in Southern California. I took this time to build a strong
foundation that I knew would one day set me up to be a great clinician. I found myself
curious and intrigued about the pathophysiology of the patient that was being treated
while working with physicians, asking the “why” behind the medical and nursing plans of
care. I researched diseases and evidence- based nursing practices, treating the “patient”
not just the disease that was before me.
During these years in the emergency department, I realized the hospital for some,
was the only access to care. Limited access to primary care contributes to this challenge. I
witnessed a delay in care for these patients because of the lack of having their own
provider and for some, when they came to the hospital, they were more acute than they
should have been.
I stated looking towards the path of physician assistant after graduating but after
having multiple conversations with Nurse Practitioners, I knew it was the right path for
me. I applied for and was accepted into California Baptist University Family Nurse

v
Practitioner program, and I am glad I did because it was the best decision I could have
made.
Since becoming a NP, I have worked in a specialty office practice as well as have
had the opportunity to partner with a physician as my medical director in aesthetics.
Having my Doctor of Nursing Practice (DNP) will now provide the terminal nursing
degree for independent practice, closely linking the scientific field.
In summary, my nursing career as a registered nurse and as a NP along with my
life experiences where I have had to be independent and resilient, will lead me to success
and allow me to truly have an impact on patient outcomes.
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Abstract
Abstract Title: Decreasing Adverse Events by Implementing Blunt Tip Cannula in the
Administration of Dermal Fillers Intra and Post Treatment
Background: Dermal filler administration has become one of the most popular cosmetic
procedures since dermal fillers were FDA approved in 1981. Although decreasing
adverse events in dermal filler administration is a primary concern, aesthetic providers
strive to provide patients with the most comfortable treatment experience possible
without compromising aesthetic outcomes. Evidence has suggested that blunt tip
cannulas provide a more comfortable delivery of dermal fillers and a lower risk of
adverse events when compared with the standard practice of using a hypodermic needle.
However, there is little clinical data comparing intra-procedure and post-procedure
adverse events of the two techniques.
Purpose: The primary purpose of this evidence-based project is to compare adverse
events when using either a blunt tip cannula, or the standard procedure of a hypodermic
needle for the administration of dermal filler. Facial injections of dermal filler using a
blunt tip cannula were compared to patients that were previously injected using a
hypodermic needle. Pain/discomfort and the overall desired aesthetic effect of the two
techniques were evaluated for statistical significance and best practice application.
Methods: 73 total patients, including both male and female adults, ages 24-77 years old,
seeking facial augmentation using hyaluronic acid dermal fillers were included in the
evidence-based project. Individuals who were pregnant, lactating or had received dermal
fillers within the past 24 months were excluded. Once the participants were consented for
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the treatment and a photo release was obtained, participants were prepared for
administration of dermal fillers via a blunt tip cannula. Each injection site was cleaned
using Isopropyl Alcohol and 4% Chlorhexidine Gluconate. Topical anesthesia was
provided by applying a topical cream consisting of Benzocaine, Tetracaine and
Lidocaine, 15 minutes prior to beginning the procedure. As part of the standard procedure
for cannula insertion, a 20-gauge hypodermic needle was used to make an entry point for
insertion of the cannula into the correct dermal plane. Administration of hyaluronic acid
into the anterior and lateral mid-face was then performed using a retrograde injection
technique. The treatment area was then compared to the data sets of patients previously
injected with the standard practice hypodermic needle for pain, and aesthetic outcome.
Patients were evaluated intra-procedure, immediately post-procedure procedure and then
again 14 days after the treatment. Pain was assessed and recorded using the Wong Baker
FACES pain scale whereas 0 is no pain, 1 is the least amount of pain and then increases
to 10, with 10 as the most pain possible. Aesthetic outcome was measured by utilization
of the Global Aesthetic Improvement Scale (GAIN). The GAIN measuring tool is a 5point scale rating and measuring the aesthetic improvement in appearance. The degree
and description are as follows; 5 is very much improved with an excellent corrective
result, 4 is much improved with a marked improvement of the overall appearance but not
completely optimal, 3 is an improvement compared to the initial condition, but an
additional treatment may be needed, 2 is unchanged and the appearance remains the same
compared with the original condition and 1 is a worsened where the appearance has
worsened compared to the original condition.
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Results: 14 days post treatment, all patients who were injected with dermal fillers by the
blunt tip cannula overall had less pain and discomfort compared to the data set of patients
that were treated by the hypodermic needle. In addition, all 73 patients scored a 5 on the
GAIN improvement scale reporting a significant increase in overall aesthetic effect and
outcome.
Conclusion: When compared to the standard procedure of dermal filler administration by
hypodermic needle, blunt tip cannula administration results in less pain and bruising with
no decrease in aesthetic outcome. The addition of the blunt tip cannula to the clinical
setting should be considered by providers who seek to provide their patients with
techniques that offer less pain and bruising without compromising aesthetic outcome.
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Background and Significance
Injections of dermal fillers are one of the most common aesthetic procedures done
worldwide (Vedamurthy, 2010). Dermal filler administration provides minimally
invasive and cost-effective alternatives to traditional facial plastic surgery, however
dermal filler treatments come with complications and adverse effects. Having a thorough
understanding of facial anatomy is important in preventing adverse effects when injecting
dermal fillers. Injectors need to be aware of preventative measures, including different
injection techniques, such as using the blunt tip cannula, to minimize the risk of adverse
events and improve patient outcomes (H, 2019). It is important that providers are
properly trained on injection techniques developed from evidence-based practice.
Training and continuing education in new dermal filler techniques while ensures the
provider is practicing in the safest manner possible. Nationally medical spas are
experiencing an increase in adverse events such as bleeding, bruising, pain/discomfort,
and more serious events such as stroke and blindness have also been reported. The
increase in these adverse events make it apparent that providers should implement the
safest techniques available A patient care “need” that has been identified is addressing
the number of adverse effects during and after the patient dermal filler injections.
Purpose/Aims
In aesthetic medicine the need for practical guidance in executing evidence
-based practice in the medical spa or other aesthetic clinical settings is overdue. The
purpose of this evidence-based practice project was to see a decrease in adverse events
such as pain and discomfort to those adult patients receiving dermal fillers using the blunt
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tip cannula. The patient pain levels were compared to a previous data set of patients who
received dermal fillers using the hypodermic sharp needle. The patients desired outcome
would remain the same, if not better using the blunt tip cannula for these aesthetic
treatments.
Introduction to the Evidence
A review of the literature was done by electronic searches using key words such
as: dermal fillers, blunt tip cannula, hypodermic sharp needle, hyaluronic acid, and
adverse events. The data provided on dermal filler injection technique and the adverse
effects were collected from articles within OVID, CINHAL, PubMed, Science Direct and
Google Scholar.
Literature Review/Evidence for the Problem
There were multiple case studies and journal articles that were reviewed in
determining what the best and safest injection technique would be for the aesthetic
patient. In a clinical study titled “Filler injections with the blunt tip microcannula
compared to the sharp hypodermic needle,” the main objective was to compare the
different injection sites where dermal filler was placed with microcannulas versus the
hypodermic needles. The study explained and described the amount of dermal filler
required to achieve the desired aesthetic outcome for the patient, the pain experienced by
patient, and the adverse events including bleeding and bruising and to demonstrate the
advantages of single-port injection technique with the blunt-tip microcannula (Fulton,
2012). According to the study, ninety-five patients participated between 30-76 years of
age, all with the desire to have facial and hand augmentation for antiaging purposes and
were injected with either needle or cannula. One limitation regarding this study was the
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small number of participants in the study. This limitation would not affect the practice
policy/change because the outpatients setting where the changes would be implemented
is relatively small and is comparable to the study reviewed. Although the participate
number was small, the results did provide enough data to change and make decisions for
best practice.
The clinical study evaluated patients using the GAIN scale (Global Aesthetic
Improvements Scale). This scale is a measurement of the patient improvement post
treatment compared to pretreatment and is a 5-point scale measured by the investigator.
The GAIN results were excellent (55%), moderate (35%), and somewhat improved
(10%) one month after the procedure, decreasing to excellent (23%), moderate (44%),
and somewhat improved (33%) at the six-month evaluation for both the hypodermic
needle and microcannula injections. Patients that experienced pain during injections was
described as mild for the microcannula and moderate for the hypodermic sharp needle
injection. Mild erythema was observed immediately after injection, that later resolved
after a few hours. Bruising was minimal following the microcannula injections but more
significant with the hypodermic needle and several cases developed a hematoma
following the hypodermic needle injections (Fulton, 2012).
In another clinical study twenty patients age ranges 45-72 were injected with a
calcium hydroxylapitate dermal filler using a blunt tip cannula. These participants agreed
not to engage in other facial treatments for the 30-day study duration. The purpose of this
study was to assess safety and effectiveness when injecting the dermal filler by using two
methods of delivery: the blunt tip cannula and the traditional sharp needle. The study
compared pain levels as well as injector assessed esthetic effectiveness and correction
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after treatment. This was a split-face, 30- day study and all patients that were injected
with both the sharp needle and the blunt tip cannula. These patients were treated to full
correction for volume loss to the nasal labial folds bilaterally.
Immediately following the procedure, all patients determine their pain levels by using the
10-point Visual Analogue Scale (VAS). This scale measures pain 0-10 with 0 being no
pain and 10 being the worst pain. All patients confirmed that there was equal or less pain
on the side of the face treated with the blunt tip cannula vs the side treated with the sharp
needle. The patients report pain from cannula as a 0-5 with the cannula and a 0-7.5 with
the sharp needle (Beer, 2014).
This study found that the needle caused more of the most common adverse events
including bruising, pain, swelling and redness immediately after treatment, 3 days post
treatment and 14 days post treatment.
In summary, this study shows that the blunt tip cannula can help limit the
number of adverse events caused by injection because of its specific design. They provide
safe an effective treatment without compromising the result of the treatment. The
improvement in patient comfort and procedural outcomes would lead providers to
advocate for blunt tip cannula injections over the sharp needle.
In the last study reviewed, it is said that injection-related side effects and
complications are likely to occur during or after filler injections; they are mainly caused
by the injection technique. Having an increase in the availability of dermal fillers has led
to an increase in their application. Understanding the risks and benefits in using the
different techniques can help providers diagnose, avoid, and manage complications when
injecting. The main objective of this study was to assess the safety and efficacy of a
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metallic cannula to inject dermal fillers but also to compare the safety of the cannula to
the sharp needle. The study consisted of 25 participants all with either a grade two or
three on the Modified Fitzpatrick Wrinkle Scale. The injections were randomized and the
0.5ml of a hyaluronic dermal filler was injected by needle or cannula.
The results showed that during injection, immediately after and up to day 3 post
treatment, all patients reported less adverse effects such as, swelling, bleeding and
bruising done by cannula than those who had needle injections. The overall conclusion of
the study is that cannula is shown to cause less adverse effects and is a safe tool to deliver
hyaluronic acid fillers (Hexsel et al., 2012).
Aesthetic treatments are becoming more popular and due to the changing goals in
treatment, aiming to improve the patient experience and decrease adverse events should
be the goal. The sharp needle technique for injection is still used in most medical spas
worldwide but using the blunt tip cannula has been shown and proven to deliver the same
aesthetic outcome desired by the patient with a decrease in downtime due to adverse
events. Although the studies only had a small number of participants the outcomes are
consistent and present strong enough evidence that cannula technique should be and will
be used in augmenting facial features using hyaluronic acid fillers. Once implementing
the cannula technique into practice, the expected number of adverse events should be less
than those who received hyaluronic acid fillers by needle technique. This would provide
better patient outcomes from both a safety and aesthetic standpoint. Although dermal
filler administration is a relatively low risk procedure, research highlights that provider
technique and knowledge of anatomy are important factors in decreasing the risk of AE
(van Loghem, Humzah & Kerscher, 2016).
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Evidence-Based Practice Model
Evidence based practice (EBP) models and frameworks are designed to guide
healthcare practitioners to deliver the best and safest quality care to patients. There are
multiple EBP models because no one model can meet the needs of the nursing and/or
healthcare environment. For this project, the model chosen and used was the PARiSH
model. Healthcare is ever changing, and the evidence-based practice models are designed
to provide a systematic guide to implementation of evidence-based practice (Melnyk,
Bernadette Mazurek, Ph.D. & Fineout-overholt, 2019). In medical spas nationwide more
and more adverse events are taking place such as increased, bleeding, bruising,
pain/discomfort, and more serious events such as stroke and blindness have also been
reported. The opportunity for improvement and the need for change in injection
technique by the providers is apparent. The PARiSH model described three elements and
they are: evidence, context, and facilitation (Rycroft-Malone, 2008) . The goal is to see a
reduction in adverse events in patients after dermal filler injections. This would be
measured by patient call backs, complaints about discomfort and/pain during treatments
and patient chart review. According to the PARiSH model this is considered part of the
“evidence” element. The Iowa model would also consider this as “Identifying Triggering
Issue,” both are similar in this first step (Melnyk, Bernadette Mazurek, Ph.D. & Fineoutoverholt, 2019). This evidence would then be shared among all staff members, so all
healthcare team members understand the need, the options on how else to treat patients
and share the vision.
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The next step is to gather the evidence that supports an increase in patients’
outcomes receiving treatments not done with a needle but a blunt tip cannula. The
cannula technique is less invasive but still provides the aesthetic outcome the patient’s
desire. The data would be gathered from patient call logs, patient charts, including patient
photos, and provider documentation. These changes, if agreed upon and after teaching
has been completed, would be made in clinic. They are relevant to the organization and
the resources are available to implement the change in practice, this section of the
implementation model falls under “context” in the PARiSH framework and is more
“clinic specific” than the Iowa Model. Lastly, the PARiSH model describes “facilitation”
as the third and final element. The support needed for successful change in the clinic
would be needed by all staff, not just the injectors. Implementing change such as learning
new techniques takes time and may lead to longer patient visits, not just for the treatment
itself at first but also the educational piece from the provider to the patient. Even though
all staff members will be aware of the change being made there may be one or two
individuals who may be the clinic “facilitator.” They will take on the role of an
“educator” during this process. Their role would include but will not be limited to:
educating injectors who already have the foundation, supporting their growth, answering
staff and patient questions. They will then meet with the medical director to review charts
to see if the change in practice has made a positive change in adverse events in patients
receiving dermal fillers by cannula technique.
Successful implementation of new evidence to a clinic is most likely to occur
when all staff and healthcare team members are receptive to change and when it aligns
with the mission and vison of the clinic (Rycroft-Malone, 2008)
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Methods
A total of 73 adult patients, both male and female, ages 24-77 years old, seeking facial
augmentation using hyaluronic acid dermal fillers were included in the evidence-based
project. Once the participants were consented for the dermal filler treatment, each
injection site was cleaned using Isopropyl Alcohol and 4% Chlorhexidine Gluconate.
Topical anesthesia was provided by applying a topical cream consisting of Benzocaine,
Tetracaine and Lidocaine, 15 minutes prior to beginning the procedure. As part of the
standard procedure for cannula insertion, a 20-gauge hypodermic needle was used to
make an entry point for insertion of the cannula into the correct dermal plane.
Administration of hyaluronic acid into the anterior and lateral mid-face was then
performed using a retrograde injection technique. The treatment area was then compared
to the data sets of patients previously injected with the standard practice hypodermic
needle for pain, bruising and aesthetic outcome. Patients were evaluated intra-procedure,
immediately post-procedure procedure and then again 14 days after the treatment. Pain
was assessed and recorded using the Wong Baker FACES pain scale whereas 0 is no
pain, 1 is the least amount of pain and then increases to 10, with 10 as the most pain
possible. Aesthetic outcome was measured by utilization of the Global Aesthetic
Improvement Scale (GAIN). The GAIN measuring tool is a 5-point scale rating and
measuring the aesthetic improvement in appearance. The degree and description are as
follows; 5 is very much improved with an excellent corrective result, 4 is much improved
with a marked improvement of the overall appearance but not completely optimal, 3 is an
improvement compared to the initial condition, but an additional treatment may be
needed, 2 is unchanged and the appearance remains the same compared with the original
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condition and 1 is a worsened where the appearance has worsened compared to the
original condition.
Ethical Considerations
This study was approved by the Institutional Review Board of the University of
San Diego, Hanh’s School of Nursing.
Results
The average pain reported was a 4.3 on the Wong Baker Pain scale intra
procedure with the blunt tip cannula compared to a 6.7 of those who were previously
injected with the hypodermic needle. The average pain post procedure with the blunt tip
cannula was 2.7 compared to 4.8 with the hypodermic needle. After 14 days, the patients
that were injected with the blunt tip cannula reported zero pain compared to those who
were injected with the hypodermic needle with the average pain of 2. All patients who
received dermal fillers reported a 5 on the GAIN aesthetic improvement scale for
improvement and overall excellent correction to the area treated with dermal fillers.

Figure 1: Patient Pain Scale Intra and Post Treatment
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Study Limitations
The sample size for this project was small and it would be recommended to
conduct this on a larger sample size of both male and female adults. Most of the patients
treated did not have a history of dermal filler treatments or other minimally invasive
procedures. Of the 73 adult patients, 56 were female leaving very few male patients for
this project. Having equal number of males to female patients could provide more
detailed report. Additional studies should be done to compare injectors with similar levels
of experience and injection volumes to identify any technique differences that may be
helpful in decreasing the patient’s pain and discomfort intra and post treatment.
Conclusion
Cannulas have recently become a viable alternative to needles because cannulas
seem to be associated with fewer adverse effects. Unlike the sharp hypodermic needle,
the blunt tip cannulas are round and can be flexible, allowing a greater ability to
administer dermal fillers allowing the injector to fill different areas of the face. They
provide advantages in reducing pain with a degree of correction compared to the needle,
therefore the addition of the blunt tip cannula to the clinical setting may be appropriate.
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Appendix D
USD DNP Program Outcomes Exemplars
USD Program Hours-1000 upon completion
California Baptist University MSN program hours-540 completed
Natalie Drone MSN, RN, FNP-C
Fall 2020 Hours: 34
DNP Essential I:
• Fall 2020:
o Collaborative Institutional Training Initiative completion
• Spring 2021
o Quality Initiatives
DNP Essential II:
• Fall 2020:
o PICOT question for evidence-based practice project formulation
o Hypertension screening program formulation
• Spring 2021
o Continued project for DNP scholarly practice
DNP Essential III:
• Fall 2020
o Researched evidence through online data bases to find evidence to
decrease adverse events intra and post injection in the adult dermal filler
patient.
o Hypertension guideline power point presentation using the Agree II tool
• Spring 2021
o Finalized literature and barriers to implementation for final project
DNP Essential IV:
• Spring 2021
o Analyzing data, trends, and graphs for the final EBP project
DNP Essential V:
• Fall 2020
o Active member of California Association of Nurse Practitioners
o Active member of American Academy of Emergency Nurse Practitioners
o Active member of American Med Spa Association
• Spring 2021
o Active member of CANP, discussed with members the impact Bill AB
890 will have and how it benefits patients across the state of California if
Nurse Practitioners were practicing independently. Reached out to key
speakers and ambassadors about AB 890.
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•

Fall 2021
o Continued involvement with ambassadors and key representatives
discussing Bill AB 890

DNP Essential VI:
• Fall 2020
o Presented EBP project to Allergan and Galderma representatives. The
focus was “why” we are contemplating our dermal filler injection
techniques to increase positive patient outcomes
• Spring 2021
o Developed and action plan for Providence St. Mary Medical Center, to
implement their vision of “Health for a Better World.”
o Continued scholarly practice EBP
• Summer 2021
o Required readings and class presentations on culturally competent care.
o Continued EBP project and finalized literature review for final manuscript
DNP Essential VII:
• Fall 2020
o Hypertension levels of prevention screening program project
o Focused on the population at risk
o Provided education on hypertension
DNP Essential VIII:
• Fall 2020
o Demonstrated advanced levels of clinical judgment in clinic and the
emergency department structured around EBP to ensure positive patient
outcomes and patient safety
o IRB
• Summer 2021
o Mindfulness through Sacred Encounters Power Point Presentation
o Continued providing competent care to patients

